Revitas Achieves Record Results with Focus and Investment in Client
Success

Strong momentum continues for Revitas with customer roster that
includes the top 10 pharmaceutical companies, as well as global
commercial manufacturers

February 03, 2016 09:02 AM Eastern Daylight Time

PHILADELPHIA--(EON: Enhanced Online News)--Revitas,
Inc. continues to demonstrate exceptional momentum in both the life
sciences and commercial manufacturing sectors. For the past 18 months,
Revitas has focused on a core set of priorities, including investment in
its life sciences platform, expansion into new vertical markets, and
delivery of new solutions, including a SaaS multi-tenant platform and
comprehensive global offering. This focus, combined with a vigorous
commitment to client success, has resulted in record sales and financial
performance, and tremendous momentum as the company enters 2016.

“What Revitas
achieved in 2015 was outstanding, but it’s only a preview of what’s to
come as the company expands its leadership position in life sciences,
cultivates new products and markets, and further establishes its
presence as a world-class development organization.”

Revitas currently serves all of the top 10
pharma companies and released its long-term platform for the life
sciences industry in December, representing a significant investment in
the foundational elements that life sciences clients rely upon. Revitas
will provide continuous support and enhancements for this platform as
well as future-proof solutions in recognition of the material investment
clients make in its solutions. Revitas’s strategic product roadmap
includes five new life sciences solutions and a SaaS multi-tenant
solution that will be available later this year.

“We worked closely with our clients, partners, and advisors last year to
develop our business strategy and remained highly focused on execution
and delivery. The ultimate testimonial is winning new customers and
seeing current customers adopt our new platform and solutions. Revitas
has won more than 75 percent of the life sciences decisions over the
past 24 months, and nearly 100 percent over the past 12 months. In
addition, the majority of our large enterprise clients are implementing
our new life sciences platform. Realizing this level of market
acceptance is the best endorsement of our work, and provides validation
that we have set the right course and invested in the right areas,” said Brian
Madocks, President and CEO at Revitas.

“As Revitas’s suite of products evolves, the company’s vision remains
the same – to be the preeminent revenue, channel, and contract
management solutions provider, and offer clients unique, customizable
tools to elevate their businesses,” continued Madocks. “What Revitas
achieved in 2015 was outstanding, but it’s only a preview of what’s to
come as the company expands its leadership position in life sciences,
cultivates new products and markets, and further establishes its
presence as a world-class development organization.”

For more information about Revitas’s channel, revenue, and contract
management solutions, visit www.revitasinc.com.

About Revitas

Revitas is the leading provider of enterprise-class solutions for
channel and contract management, on premise and in the cloud. Revitas
solutions enable organizations to accelerate revenue through diverse,
multi-level sales channels and attain maximum value from contracts. For
over 25 years, Revitas has empowered companies in channel-intensive
industries to achieve best-in-class performance and sustainable
competitive advantage. For more information, please visit www.revitasinc.com.